Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Active Not Recruiting NA INTERVENTIONAL NCT02543320

Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

This pilot trial studies how well neurofeedback training works in decreasing acute radiotherapy-induced pain in patients with head and neck cancer. Neurofeedback training is a type of therapy that uses electroencephalograph and a computer software program to measure brain wave activity. Neurofeedback training may help teach patients ways to modify their own brain waves to decrease the perception of pain and improve quality of life.

Detailed Description

PRIMARY OBJECTIVES: I. Determine the effects of an individualized LORETA (low resolution electromagnetic tomography) Z score neurofeedback program on changes in brain function using EEG (electroencephalography), qEEG (quantitative electroencephalography), and LORETA from immediately before to after each session in patients with head and neck cancer undergoing radiotherapy and experiencing pain. SECONDARY OBJECTIVES: I. Examine the effects of an individualized LORETA Z score neurofeedback program on perceptions of radiation-induced pain in head and neck cancer patients from immediately before neurofeedback training to immediately after neurofeedback training. II. Identify brain regions from qEEG and LORETA that are associated with a non-pain state and then an acute pain state. III. Examine the relationship between the patient and their spouse or primary caregiver. OUTLINE: Beginning at weeks 4 and 5 or 5 and 6 of radiotherapy, patients undergo neurofeedback training once per day (QID) three times per week (TIW) for up to 6 treatments. Patients also complete questionnaires over 10 minutes at baseline and after neurofeedback training. After completion of study, patients are followed up at 1 week.

Interventions

Name: LORETA Neurofeedback Training
Type: OTHER
Description: Undergo LORETA neurofeedback training
Name: Questionnaire Administration
Type: OTHER
Description: Ancillary studies

Primary Outcomes

Measure: EEG
TimeFrame: Baseline up to 1 week
Description: The qEEG normative database is grouped by age and contains a sufficiently large sample size with means and standard deviations of the EEG time series and/or frequency domain analysis computed for each age group.
Measure: Neurofeeback (LORETA)
TimeFrame: Up to 5 years
Description: The LORETA software package is used to perform the statistical analyses. The methodology used is non-parametric. It is based on estimating, via randomization, the empirical probability distribution for the max-statistic (e.g. the maximum of a t or an F statistic), under the null hypothesis. This methodology corrects for multiple testing (i.e., for the collection of tests performed for all electrodes and/or voxels, and for all time samples and/or discrete frequencies. Due to the non-parametric nature of the method, its validity need not rely on any assumption of Gaussianity.

Trial Information

NCT ID

NCT02543320

Status

Active Not Recruiting

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

M.D. Anderson Cancer Center

Last Updated

December 15, 2025